Cost Effectiveness of Shortening Screening Interval or Extending Age Range of NHS Breast Screening Programme: Computer Simulation Study
To compare the cost effectiveness of two possible modifications to the current UK screening programme.
Breast Cancer
Breast Cancer
Breast cancer is one of the most common forms of cancer and the second leading cause of cancer death in women. It is also one of the most detectable and treatable cancers, and mortality has been declining over the past 20 years. RAND research has focused on the care of breast cancer and its side effects, as well as the secondary factors that influence detection, treatment, and recovery.